Artificial Intelligence-assisted Colonoscopy on Detection of Missed Proximal Lesions

Sponsor
The University of Hong Kong (Other)
Overall Status
Completed
CT.gov ID
NCT04294355
Collaborator
Tan Tock Seng Hospital (Other), Institute of Gastroenterology and Hepatology, Vietnam (Other)
216
3
2
13.5
72
5.3

Study Details

Study Description

Brief Summary

This is a prospective multi-center randomized study is to determine whether the use of artificial intelligence (AI)-assistance could reduce the miss rates of polyps and adenomas in the proximal colon during tandem examination

Condition or Disease Intervention/Treatment Phase
  • Device: Artificial intelligence-Assisted colonoscopy
  • Procedure: Conventional colonoscopy
N/A

Detailed Description

Centers

  1. Queen Mary Hospital, Hong Kong, China (Co-ordinating Center)

  2. Tan Tock Seng Hospital, Singapore, Singapore

  3. Institute of Gastroenterology and Hepatology, Vietnam Union of Science and Technology Association, Hanoi, Vietnam

Study population

Inclusion:

All adult patients, aged 40 or above, undergoing outpatient colonoscopy in the participating centers will be recruited.

Exclusion:
  • history of inflammatory bowel disease

  • history of colorectal cancer

  • previous bowel resection (apart from appendectomy)

  • Peutz-Jeghers syndrome, familial adenomatous polyposis or other polyposis syndromes

  • bleeding tendency or severe comorbid illnesses for which polypectomy is considered unsafe.

Post-randomization exclusion:
  • Cecum could not be intubated for various reasons

  • Boston Bowel Preparation Scale (BBPS) score of the proximal colon is <2

Study design This is a prospective randomized trial comparing the miss rates of proximal colonic lesions by AI assisted colonoscopy or conventional colonoscopy (Fig. 1). The study will be conducted in the Endoscopy Centre of the participating hospitals.

Randomization Eligible patients in each center will be randomly allocated in a 1:1 ratio to undergo tandem colonoscopy of the proximal colon first with AI-assistance and follow by conventional white light colonoscopy (Group 1) or conventional white light colonoscopy without AI assistance follow by conventional colonoscopy (Group 2). Proximal colon refers to colonic segment proximal to the splenic flexure. Randomization will be conducted in blocks of 4 by computer generated random sequences and stratified according to indications of colonoscopy (symptomatic vs screening/surveillance). Patients will be blinded to the group assignment.

Study Design

Study Type:
Interventional
Actual Enrollment :
216 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Prospective randomized designProspective randomized design
Masking:
Single (Participant)
Primary Purpose:
Diagnostic
Official Title:
Artificial Intelligence-assisted Colonoscopy Versus Conventional Colonoscopy for Missed Lesions in the Proximal Colon: A Prospective Multi-center Randomized Study in Asia
Actual Study Start Date :
Mar 1, 2021
Actual Primary Completion Date :
Mar 31, 2022
Actual Study Completion Date :
Apr 15, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Artificial intelligence-Assisted colonoscopy

Tandem colonoscopy of proximal colon assisted with artificial intelligence followed by conventional colonoscopy

Device: Artificial intelligence-Assisted colonoscopy
Artificial intelligence-Assisted colonoscopy for detection of colonic polyp

Procedure: Conventional colonoscopy
Conventional colonoscopy

Active Comparator: Conventional colonoscopy

Tandem conventional colonoscopy of proximal colon followed by usual conventional colonoscopy

Procedure: Conventional colonoscopy
Conventional colonoscopy

Outcome Measures

Primary Outcome Measures

  1. Proximal adenoma missed rate [One day]

    The proportion of patients with missed adenomas detected in the second examination only

Secondary Outcome Measures

  1. Proximal polyp missed rate [One day]

    The proportion of patients with missed adenomas detected in the second examination only

  2. Proximal adenoma detection rate [One day]

    The proportion of patients with at least one adenoma

  3. Proximal polyp detection [One day]

    The proportion of patients with at least one polyp

Eligibility Criteria

Criteria

Ages Eligible for Study:
40 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • All adult patients, aged 40 or above, undergoing outpatient colonoscopy in the participating centers will be recruited
Exclusion Criteria:
  • history of inflammatory bowel disease

  • history of colorectal cancer

  • previous bowel resection (apart from appendectomy)

  • Peutz-Jeghers syndrome, familial adenomatous polyposis or other polyposis syndromes

  • bleeding tendency or severe comorbid illnesses for which polypectomy is considered unsafe.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Queen Mary Hospital Hong Kong China
2 Tan Tock Seng Hospital Singapore Singapore
3 Institute of Gastroenterology and Hepatology Hanoi Vietnam 0

Sponsors and Collaborators

  • The University of Hong Kong
  • Tan Tock Seng Hospital
  • Institute of Gastroenterology and Hepatology, Vietnam

Investigators

  • Principal Investigator: Ka Luen, Thomas Lui, MBBS, Queen Mary Hospital, the University of Hong Kong
  • Study Director: Wai Keung Leung, MD, Queen Mary Hospital, the University of Hong Kong

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
The University of Hong Kong
ClinicalTrials.gov Identifier:
NCT04294355
Other Study ID Numbers:
  • UW 19-713
First Posted:
Mar 4, 2020
Last Update Posted:
Apr 21, 2022
Last Verified:
Apr 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by The University of Hong Kong
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 21, 2022